Birth outcomes of cases with right sided obstructive defects of heart a population-based case-control study
Abstract
Background: Among structural birth defects, i.e. congenital abnormalities, the most common group includes congenital heart defects (CHDs), however, the underlying causes are unclear in the vast majority of cases with CHD.
Objectives: Cases with different CHD-entities as homogeneously as possible are planned to evaluate. Thus the medically recorded birth outcomes of lethal or surgically corrected cases with different groups of right sided obstructive defects of heart (RSODH) were evaluated.
Method: The population-based large dataset of the Hungarian Case-Control Surveillance of Congenital Abnormalities was used and date were analyzed between 1980-1996, including 200 live-born cases with isolated RSODH, 72, 13,7 and 108 had congenital stenosis of pulmonary valve, atresia/stenosis of tricuspid valve, Ebsteins anomaly, and atresia/stenosis of pulmonary artery, respectively compared to 304 matched controls and 38,151 population controls without any defects.
Results: A higher rate of preterm birth and low birthweight was found in cases with RSODH born in somewhat elder women with higher birth order and lower socioeconomic status. However, 4 groups of RSODH were different from epidemiological aspect, and the degree of intrauterine growth restriction depended on the group of RSODH and the sex of fetuses.
Conclusions: The pathogenesis-oriented classification of RSODH is not associated with similar epidemiological birth outcomes of cases with different RSODH groups.
About this article
References
Czeizel AE, Kamarás J, Balogh Ö, Szentpéteri J, “Incidence of congenital heart defects in Budapest”, Acta Paediat Acad Sci Hung, 13, 3, (1972), pp. 191-202.
Hoffman JIE, Kaplan S, “The incidence of congenital heart disease”, J Am Coll Cardiol, 39, 12, (2002), pp. 1890-1900.
Calzolary E, Garani G, Cocchi G, Magnani C, Rivieri F, Neville A, Astolfi G, Baroncini A, Garacelli L, Gualandi F, Scorrano M, Bosi G, IMFR Working Group, “Congenital heart defects: 15 years of experience of the Emilia-Romagna Registry (Italy)”, Eur J Epid, 18, 8, (2003), pp. 773-780.
Hoffman JIE, Kaplan S, Liberthson RR, “Prevalence of congenital heart disease”, Am Heart J, 147, 3, (2004), pp. 425-439.
Dolk H. Loane M, Garne R, European Surveillance of Congenital anomalies (EUROCAT) Working Group, “Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005”, Circulation, 123, 8, (2011), pp. 841-849.
View more references (26)
Mészáros M, Nagy A, Czeizel AE, „Incidence of congenital heart disease in Hungary”, Hum Hered, 25, 6, (1975), pp. 513-519.
Fulton DR, Congenital heart diseases in children and adolescent, In: Fuster V, Wals A, O’Rourke RA, Poole-Wilson P (eds.) Hurst’s the Heart, 12th edn., New York, McGraw Hill Medical, (2008), pp. 1855-1921.
Czeizel AE, Sankaranarayanan K, “The load of genetic and partially genetic disorders in man. Congenital anomalies: estimates of detriment in terms of years of life lost and years of impaired life”, Mutat Res, 128, 1, (1984), pp. 73-103.
Gelb BD, “Genetic basis of congenital heart disease”, Curr Opin Cardiol, 19, 2, (2004), pp. 110-115.
Pierpont ME, Basson CT, Benson DW, Gelb BD Jr, Giglia TM, Goldmuntz E, McGee G, Sable CA, Srivatava D, Webb CL, “Genetic basis for congenital heart defects: current knowledge”, Circulation, 115, 23, (2007), pp. 3015-3038.
Jenkins KJ, Correa A, Feinstein JA, Botto L, Britt AE, Daniels SR, Elixson M, Warnes CA, Webb CL, “Noninherited risk factors and congenital cardiovascular defects: current knowledge”, Circulation, 115, 23, (2007), pp. 2995-3014.
Rassmussen SA, Erickson JD, Reef SE, Ross DS, “Teratology: from science to birth defects prevention”, Birth Defects Res Part A Clin Mol Teratol, 85, 1, (2009), pp. 82-92.
Ferencz C, Loffredo CA, Rubin JD, Magee CA, Epidemiology of Congenital Heart Diseases. The Baltimore-Washington Infant Study: 1981-1989, Future Publ. Co., Mount Kisco, N. Y., (1983).
Ferencz C, Loffredo CA, Correa-Villasenor A, Wilson PD, Genetic and Environmental Risk Factors of Major Cardiovascular Malformations: The Baltimore-Washington Infant Study: 1981-1989, Futura Publ Co, Armonk, N. Y., (1997).
Clark EB, Mechanism in the pathogenesis of congenital heart defects, In: Pierpont MEM, Moller JH (eds.): The Genetics of Cardiovascular Disease, Martinus-Nijoff, Boston, (1987), pp. 3-11.
Czeizel AE, Rockenbauer M, Siffel Cs, Varga E, “Description and mission evaluation of the Hungarian Case Control Surveillance of Congenital Abnormalities, 1980-1996”, Teratology, 63, 5, (2001), pp. 176-185.
Czeizel AE, “The first 25 years of the Hungarian Congenital Abnormality Registry”, Teratology, 55, 5, (1997), pp. 299-305.
Czeizel AE, Intődy Zs, Modell B, “What proportion of congenital abnormalities can be prevented?”, Brit Med J, 306, 6876, (1993), pp. 499-503.
Czeizel AE, Petik D, Vargha P, “Validation studies of drug exposures in pregnant women”, Pharmacoepid Safety, 12, 5, (2003), pp. 409-416.
Czeizel AE, Vargha P, “Periconceptional folic acid/multivitamin supplementation and twin pregnancy”, Am J Obstet Gynecol, 191, 3, (2004), pp. 790-794.
Czeizel AE, Petik D, Puho E, “Smoking and alcohol drinking during pregnancy. The reliability of retrospective maternal self-reported information”, Centr Eur J Publ Health, 12, 4, (2004) pp. 179-183.
Ács N, Bánhidy F, Puho E, Czeizel AE, “Maternal influenza during pregnancy and risk of congenital abnormalities in offspring”, Birth Defects Res Part A Clin Mol Teratol, 73, 12, (2005), pp. 989-995.
Ebstein W, „Über einen sehr seltenen Fall von Insufficienz der Valvula Tricuspidalis, bedingt durch eine angeborene hochgradige Missbildung derselben“, Arch Anat Physiol Wissensch Med, 18, (1866), pp. 238-254.
Puho E, Métneki J, Czeizel AE, “Maternal employment status and isolated orofacial clefts in Hungary”, Centr Eur J Publ Health, 13, 3, (2005), pp. 144-148.
Storch TG, Mannick EE, „Epidemiology of congenital heart disease in Louisana: An association between race and sex and the prevalence of specific cardiac malformations”, Teratology, 46, 3, (1992), pp. 271-276.
Pradat O, Francannet C, Harris JA, Robert E, “The epidemiology of cardiovascular defects, part I. A study based on data from three large registries of congenital malformations”, Pediatr Cardiol, 24, 3, (2003), pp. 195-221.
Reefhuis J, Honein MA, “Maternal age and non-chromosomal birth defects, Atlanta 1968-200: teenager or thirty-something, who is at risk?”, Birth Defects Res Part A Clin Mol Teratol, 70, 9, (2004), pp. 572-579.
Miller A, Riehle-Colarusso T, Siffel C Frias JL, Correa A, “Maternal age and prevalence of isolated congenital heart defects in an urban area of the United States”, Am J Med Genet A, 155A, 9, (2011), pp. 2137-2145.
Correa-Villasenor A, McCarter R, Downing J, Ferencz C, “White-black differences in cardiovascular malformations in infancy and socioeconomic factors: the Baltimore-Washington Infant Study Groups”, Am J Epidemiol, 134, 4, (1991), pp. 393-402.
Rosenthal GL, “Patterns of prenatal growth among infants with cardiovascular malformations: Possible fetal hemodynamic effects”, Am J Epidemiol, 143, 5, (1996), pp. 505-513.
Freathy RM, Mook-Kanamori DO, Sovio U, Prokopenko I, Timpson NJ, Berry DJ, Washingtom NM, Widen F, Hottenga JJ, Kaakinen M, Lange LA, Gradfield JP, “Variants in ADCY5 and near CCNL1 are associated with fetal growth and birth weight”, Nature Genet, 42, 5, (2010), pp. 430-435.